tiprankstipranks
Trending News
More News >
Wave Life Sciences (WVE)
NASDAQ:WVE
US Market

Wave Life Sciences (WVE) Financial Statements

Compare
1,161 Followers

Wave Life Sciences Financial Overview

Wave Life Sciences's market cap is currently $2.33B. The company's EPS TTM is $-0.32; its P/E ratio is -17.41; Wave Life Sciences is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 108.30M$ 113.31M$ 3.65M$ 40.96M$ 20.08M
Gross Profit$ 108.30M$ 113.31M$ 3.65M$ 40.96M$ -110.87M
Operating Income$ -110.40M$ -68.00M$ -162.72M$ -127.02M$ -153.38M
EBITDA$ -101.74M$ -58.79M$ -152.61M$ -117.18M$ -145.26M
Net Income$ -97.01M$ -57.51M$ -161.82M$ -122.25M$ -149.91M
Balance Sheet
Cash & Short-Term Investments$ 302.08M$ 200.35M$ 88.50M$ 150.56M$ 184.50M
Total Assets$ 352.21M$ 274.95M$ 146.39M$ 207.01M$ 279.24M
Total Debt$ 25.40M$ 32.12M$ 37.61M$ 29.92M$ 29.30M
Net Debt$ -276.67M$ -168.23M$ -50.88M$ -120.65M$ -155.19M
Total Liabilities$ 142.69M$ 235.32M$ 191.48M$ 174.51M$ 188.59M
Stockholders' Equity$ 209.51M$ 39.63M$ -45.09M$ 32.50M$ 90.65M
Cash Flow
Free Cash Flow$ -151.96M$ -20.55M$ -129.14M$ -89.55M$ -117.32M
Operating Cash Flow$ -151.03M$ -19.43M$ -127.78M$ -88.99M$ -115.98M
Investing Cash Flow$ -938.00K$ -1.11M$ -1.25M$ -560.00K$ -1.34M
Financing Cash Flow$ 253.89M$ 132.53M$ 67.19M$ 55.83M$ 154.54M
Currency in USD

Wave Life Sciences Earnings and Revenue History

Wave Life Sciences Debt to Assets

Wave Life Sciences Cash Flow

Wave Life Sciences Forecast EPS vs Actual EPS